Background Image
Table of Contents Table of Contents
Previous Page  46 / 68 Next Page
Information
Show Menu
Previous Page 46 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 6, November/December 2015

244

AFRICA

lungs, kidneys and adrenal glands were also excised and weighed.

Haemodynamic parameters, ECG and temperature

measurements were recorded onto the computer using the

PowerLab 4/30 data-acquisition system and the LabChart

7.3.5 software (ADInstruments, Bella Vista, Australia).

Haemodynamic and ECG data were analysed using LabChart

7 Pro BP and ECG analysis modules (ADInstruments, Bella

Vista, Australia). The ECG analysis module was preset to the

rat waveform and Bazett’s formula (QTc

=

QT/√RR) was used to

calculate the QT interval, corrected for heart rate (QTc).

Infarct size quantification

A series of 2-mm-thick ventricular transverse slices of the

frozen heart were cut from apex to base and thawed for

2,3,5-triphenyltetrazolium chloride (TTC) staining. The slices

were incubated in a solution of 1% TTC in phosphate buffer

(pH 7.4) at 37°C for 20 minutes and agitated periodically while

protected from light. The slices were then washed with the buffer

and fixed with 10% formalin to enhance contrast and stored in

the dark at room temperature for 24 hours.

The slices were placed between two glass slides and scanned on

both sides using a flatbed scanner. The ventricular infarct size was

measured as an average of the TTC-negative areas on the slices

from each heart using ImageJ software (Version 1.44p, NIH,

USA) and was expressed relative to the total ventricular area.

Lipid peroxidation assays

Markers of oxidative stress, measured as by-products of lipid

peroxidation, namely conjugated dienes (CD) and thiobarbituric

acid-reactive substances (TBARS), were quantified in the plasma

using spectrophotometric assays. CD assays were carried out

using the methods described by Esterbauer.

36

Briefly, 100

µ

l of plasma was added to 405

µ

l chloroform:

methanol (2:1). After centrifugation at 6 000

g

for 15 minutes,

the top aqueous layer was removed and the organic layer was

isolated and dried under nitrogen. Cyclohexane (250

µ

l) was

added to solubise the dry organic residue and the absorbance

was read at 234 nm on a spectrophotometer (Spectramax Plus

384, Molecular Devices and Labotec, Johannesburg, South

Africa) using Softmax Pro (Version 4.4) software. A molar

extinction coefficient of 2.95

×

10

4

/M/cm was used.

TBARS were measured using the method described by

Jentzsch

et al.

37

Briefly, 6.25

µ

l of 4mMbutylated hydroxytoluene/

ethanol and 50

µ

l of 0.2 M ortho-phosphoric acid were added

to 50

µ

l of plasma samples and vortexed. TBA reagent (6.25

µ

l), dissolved in 0.1 M NaOH, was added and the mixture was

centrifuged at 3 000

g

for two minutes to collect small volumes at

the bottom of the Eppendorf tube. The volumes were heated at

90°C for 45 minutes, placed on ice for two minutes and then left

at room temperature for five minutes before

n

-butanol (500

µ

l)

was added. Phase separation was enhanced by the addition of 50

µ

l of saturated NaCl.

The samples were vortexed and centrifuged at 12 000

g

for

two minutes and 300

µ

l of the top butanol phase was transferred

into wells and read at 532 nm on the spectrophotometer. A

molar extinction coefficient of 1.54

×

10

5

/M/cm was used. The

measurements of CD and TBARS were performed in triplicate

and the mean value was taken as the final result.

Chemicals and reagents

ISO and MgSO

4

were each dissolved in physiological saline.

The TTC buffer was made up of one part 0.1 M monosodium

phosphate (NaH

2

PO

4

) and four parts 0.1 M disodium phosphate

(Na

2

HPO

2

). Sodium pentobarbitone was purchased from Kyron

Laboratories, Johannesburg, South Africa. All other drugs and

chemicals were obtained from Sigma, Johannesburg, South

Africa.

Statistical analysis

Data are expressed as mean

±

standard error of the mean

(SEM), with

n

indicating the number of rats studied under

each condition. Statistical analysis was conducted using Prism

5 (GraphPad, USA). A box-plot analysis was conducted to

exclude outliers. The distribution of data was checked using

the Kolmogorov–Smirnov, D’Agostino and Pearson, and the

Shapiro–Wilk normality tests. Differences among multiple

groups were evaluated using analysis of variance (ANOVA),

followed by a Tukey

post hoc

test. For data not normally

distributed and for normally distributed data that failed the

Bartlett’s test, a Kruskal–Wallis test was conducted followed by

a Dunns

post hoc

test;

p

≤ 0.05 was taken as the threshold for

statistical significance.

Results

Effects of Mg

2+

on ISO-induced infarct size

Fig. 1B shows typical pictures of TTC-stained ventricular slices

cut from four different hearts. Whitish-looking, TTC-negative

areas were more prominent in the ISO-treated hearts, indicating

the presence of irreversible infarction. The infarcted areas were

patchy and more diffusely located on the myocardium, consistent

with a global type of infarction compared to well-demarcated

infarcts due to coronary artery ligation.

In contrast to the effects of ISO, the control and Mg

2+

-only

treated hearts appeared mostly red (TTC positive), suggesting

tissue viability. The quantification of infarct size in whole

ventricles is summarised in Fig. 1C, which confirms that ISO

induced significant increases in infarct size (12.79

±

5.97 vs 6.84

±

1.54% in the controls;

p

<

0.05).

Pre-treatment with Mg

2+

did not prevent or enhance the

ISO-induced infarction compared with ISO-treated rats (infarct

size: 11.67

±

6.63%;

p

>

0.05). Treatment with Mg

2+

alone did

not cause injury to the myocardium compared with the controls

(infarct size: 6.94

±

2.1%;

p

>

0.05).

Effects of ISO and Mg

2+

on body and organ weights

To examine the systemic and organ-specific effects of the various

treatments, the body weight, heart weight and the weights of the

other organs were quantified (Table 1). ISO caused a significant

increase in the heart weight:body weight ratio compared with

the controls (

p

<

0.001). Pre-treatment with Mg

2+

did not prevent

the ISO-induced increase in heart weight:body weight ratio.

Compared with the control, ISO also caused a loss in body

weight (

p

<

0.05), and pre-treatment with Mg

2+

did not rectify

this weight loss.

Compared with ISO‑treated rats, Mg

2+

co-treatment also

did not affect the weights or the gross appearances of the liver,